AI in Clinical Trials Market Research 2026: Market to Reach $18.62 Billion by 2040 with IQVIA, Medidata, IBM Watson, Oracle, and Phesi Leading Through Integrated Data and Patient Matching Platforms

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Clinical trials consume roughly 50-70% of drug development timeline and budget

  80% confidence

• Asia-Pacific currently captures a significant share of the AI in clinical trials market due to massive, diverse patient population and cost-effective operations

  80% confidence

• Many clinical trials fail due to design flaws, recruitment issues, stratification errors, and high dropout rates

  80% confidence

• Oncological disorders currently capture majority share of the AI in clinical trials market due to high volume and complexity of cancer trials

  80% confidence

• Developing novel therapeutic interventions typically spans about 10-15 years

  80% confidence

• Generative AI can potentially cut drug development time by 50% and costs by 25%

  80% confidence

• The global artificial intelligence in clinical trials market size is estimated to grow from USD 2.09 billion in 2026 to USD 18.62 billion by 2040, at a CAGR of 17.0%

  80% confidence

• Digital twins enable smaller clinical trials with higher statistical power by simulating individual patient responses

  80% confidence

Cited in these Via News reports

• Big Tech AI Models Force Specialized Language Startups to Close as Investors Flee →
• Big Tech AI Releases Trigger Investor Flight from Small Language Model Startups Globally →
• Computer Vision AI Moves to Edge Processing as Healthcare and Telecom Deploy Privacy-First Systems Globally →
• Computer Vision AI Ships in Consumer Hardware Across US, Europe, Asia Markets as Edge Computing Tackles Clinical Imaging Delays →
• Enterprise AI Moves to Edge Devices as Privacy Rules and Latency Needs Force Global Shift from Cloud →
• Medical AI Diagnostics Deploy Across US, Europe as Automotive Vision Merges with Robotics →
• Medical AI Radiology Systems Enter Clinical Use in U.S. and Europe as Automotive Vision Expands to Robotics Control →